News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
146 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17596)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (15)
2 (105)
3 (184)
4 (160)
5 (95)
6 (86)
9 (195)
10 (158)
11 (164)
12 (134)
13 (88)
16 (146)
17 (115)
18 (154)
19 (154)
20 (84)
23 (128)
24 (33)
25 (4)
26 (8)
27 (6)
29 (16)
30 (34)
31 (32)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
29
30
31
Press Releases
Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024
December 16, 2024
·
1 min read
Press Releases
Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab
December 16, 2024
·
19 min read
Press Releases
Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)
December 16, 2024
·
1 min read
Press Releases
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)
December 16, 2024
·
15 min read
Press Releases
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement
December 16, 2024
·
7 min read
Press Releases
FDA Approves New Treatment for Congenital Adrenal Hyperplasia
December 16, 2024
·
3 min read
Press Releases
Quantum Biopharma Announces Closing of First Tranche
December 16, 2024
·
5 min read
Press Releases
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China
December 16, 2024
·
8 min read
Press Releases
Kelyniam Global, Inc., (“KLYG”) Announces Private Investment to Public Entity (“PIPE”) Closure of Securities Offering
December 16, 2024
·
2 min read
Press Releases
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
December 16, 2024
·
6 min read
Previous
7 of 15
Next